Posts Tagged celiac medication


Nexvax2 Financing

We have tried to post as much as we can about treatments for celiac disease and Nexvax2 seems to be leading the charge right now. This press release talks about the latest Nexvax2 financing and what the money will mean to research efforts. CAMBRIDGE, Mass., Dec. 13, 2011 /PRNewswire/ — ImmusanT, Inc. announced today it […]

Read More...

ALV003 Named a Top 10 Inflammatory/Autoimmune Project to Watch

AVL003 has shown promise as a drug to help those with celiac disease cope with the serious problems related to autoimmune and inflammatory issues caused by the disease. This press release shows that this research is getting some attention, which is greatly needed in this field. Alvine Pharmaceuticals, Inc., a biopharmaceutical company focused on the […]

Read More...

Gluten In Medications

A press release today about gluten in medications discusses a a research grant awarded by the FDA for the first scientific research on gluten in medications. Here are some excerpts from the press release. Ambler, PA, November 16, 2011 –(PR.com)– The National Foundation for Celiac Awareness (NFCA) is proud to announce that the organization has […]

Read More...

ALV003 Potential Treatment for Celiac Disease Patients

Alvine Pharmaceuticals, Inc. today (Oct 11, 2011) announced positive results from its Phase 2a clinical trial of ALV003, which demonstrated the ability of ALV003 to attenuate gluten-induced intestinal mucosal injury in serologically negative celiac disease patients maintained on a gluten-free diet for one or more years. The study findings will be presented in a late […]

Read More...